A detailed history of Guggenheim Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 1,322,993 shares of PFE stock, worth $34.9 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
1,322,993
Previous 1,430,580 7.52%
Holding current value
$34.9 Million
Previous $40 Million 4.35%
% of portfolio
0.27%
Previous 0.29%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$27.7 - $31.39 $2.98 Million - $3.38 Million
-107,587 Reduced 7.52%
1,322,993 $38.3 Million
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $1.05 Million - $1.23 Million
-41,646 Reduced 2.83%
1,430,580 $40 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $1.37 Million - $1.57 Million
52,909 Added 3.73%
1,472,226 $40.9 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $1.42 Million - $1.84 Million
54,297 Added 3.98%
1,419,317 $40.9 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $5.08 Million - $5.94 Million
158,352 Added 13.12%
1,365,020 $45.3 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $2.54 Million - $2.94 Million
70,367 Added 6.19%
1,206,668 $44.3 Million
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $3,348 - $4,358
-85 Reduced 0.01%
1,136,301 $46.4 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $1.94 Million - $2.54 Million
-46,526 Reduced 3.93%
1,136,386 $58.3 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $2 Million - $2.44 Million
-45,763 Reduced 3.72%
1,182,912 $51.8 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $7.32 Million - $8.68 Million
-157,294 Reduced 11.35%
1,228,675 $64.4 Million
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $7.31 Million - $9.06 Million
-159,853 Reduced 10.34%
1,385,969 $71.8 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $1.21 Million - $1.79 Million
29,250 Added 1.93%
1,545,822 $91.3 Million
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $2.85 Million - $3.66 Million
72,600 Added 5.03%
1,516,572 $65.2 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $629,717 - $713,364
-17,536 Reduced 1.2%
1,443,972 $56.5 Million
Q1 2021

May 13, 2021

BUY
$33.49 - $37.77 $1.36 Million - $1.53 Million
40,497 Added 2.85%
1,461,508 $53 Million
Q4 2020

Feb 16, 2021

BUY
$33.47 - $42.56 $2.5 Million - $3.18 Million
74,633 Added 5.54%
1,421,011 $52.3 Million
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $1.56 Million - $1.83 Million
-49,081 Reduced 3.52%
1,346,378 $49.4 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $2.36 Million - $2.87 Million
78,465 Added 5.96%
1,395,459 $45.6 Million
Q1 2020

Jun 02, 2020

SELL
$27.03 - $38.62 $2.22 Million - $3.18 Million
-82,260 Reduced 5.88%
1,316,994 $43 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $2.5 Million - $2.84 Million
-76,061 Reduced 5.16%
1,399,254 $54.8 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $357,390 - $463,430
11,000 Added 0.75%
1,475,315 $53 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $269,325 - $302,390
-7,283 Reduced 0.49%
1,464,315 $63.4 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $2.56 Million - $2.81 Million
68,261 Added 4.86%
1,471,598 $62.5 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $9.67 Million - $11 Million
-251,486 Reduced 15.2%
1,403,337 $61.3 Million
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $3.06 Million - $3.71 Million
88,744 Added 5.67%
1,654,823 $72.9 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $53.5 Million - $57.1 Million
-1,623,338 Reduced 50.9%
1,566,079 $56.8 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $2.39 Million - $2.77 Million
-74,915 Reduced 2.29%
3,189,417 $113 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $5.05 Million - $5.35 Million
151,711 Added 4.87%
3,264,332 $118 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $96.5 Million - $106 Million
3,112,621
3,112,621 $111 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.